Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes

Link to article at PubMed

Diabet Med. 2020 Aug 2. doi: 10.1111/dme.14378. Online ahead of print.


The RECOVERY (Randomised Evaluation of COVid-19 thERapY) trial found that dexamethasone 6 mg once per day for 10 days reduced deaths by one-third in ventilated patients and by one-fifth in other patients, receiving oxygen therapy. This equates to the prevention of one death in around eight ventilated patients, or one in around 25 patients requiring oxygen.

PMID:32740972 | DOI:10.1111/dme.14378

Leave a Reply

Your email address will not be published.